New schizophrenia drug shows promise in early brain study
Disease control
Not yet recruiting
This early study tests a new drug called SIPI6398 in 9 people (healthy volunteers and schizophrenia patients). Researchers use brain scans to see how much of the drug reaches brain receptors linked to schizophrenia. The goal is to find the right dose and check safety, not yet to …
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Zhongze Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC